AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “AMAG Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/amag-pharmaceuticals-inc
Overview
AMAG Pharmaceuticals, Inc. is a pharmaceutical company focused on developing, manufacturing, and commercializing products that address unmet medical needs. The company specializes in therapeutic areas such as maternal health, anemia management, and cancer supportive care. AMAG Pharmaceuticals was acquired by Covis Pharma in 2020 and operates under the parent company's portfolio.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2010-10-18
FDA Warning Letter (drug product)
Is this AMAG Pharmaceuticals, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.